BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16814670)

  • 21. Acadesine: a new drug that may improve myocardial protection in coronary artery bypass grafting. Results of the first international multicenter study. Multinational Acadesine Study Group.
    Menasché P; Jamieson WR; Flameng W; Davies MK
    J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):1096-106. PubMed ID: 7475138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrial natriuretic peptide protects against ischemia-reperfusion injury in rabbit hearts in vivo.
    Zhang WW; Hasaniya NW; Premaratne S; McNamara JJ
    Vasc Endovascular Surg; 2008; 42(3):263-7. PubMed ID: 18319356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of ribose, adenosine, and "AICAR" on the rate of myocardial adenosine triphosphate synthesis during reperfusion after coronary artery occlusion in the dog.
    Mauser M; Hoffmeister HM; Nienaber C; Schaper W
    Circ Res; 1985 Feb; 56(2):220-30. PubMed ID: 3918804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning.
    Skyschally A; Schulz R; Heusch G
    Herz; 2008 Mar; 33(2):88-100. PubMed ID: 18344027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological preconditioning of the heart during surgery.
    Landoni G; Figini F; Bignami E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):982-3; author reply 983. PubMed ID: 19853466
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of isoflurane-, sevoflurane-, and desflurane-induced pre- and postconditioning against myocardial infarction in mice in vivo.
    Redel A; Stumpner J; Tischer-Zeitz T; Lange M; Smul TM; Lotz C; Roewer N; Kehl F
    Exp Biol Med (Maywood); 2009 Oct; 234(10):1186-91. PubMed ID: 19596824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Old skills in a new context. But do we want to use it?
    Vaage J
    Eur J Cardiothorac Surg; 2005 Dec; 28(6):831-2. PubMed ID: 16275003
    [No Abstract]   [Full Text] [Related]  

  • 28. Brief femoral artery ischaemia provides protection against myocardial ischaemia-reperfusion injury in rats: the possible mechanisms.
    Shahid M; Tauseef M; Sharma KK; Fahim M
    Exp Physiol; 2008 Aug; 93(8):954-68. PubMed ID: 18356557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits.
    Pagel PS; Krolikowski JG
    Anesth Analg; 2009 Apr; 108(4):1076-82. PubMed ID: 19299764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICA-riboside) as a targeting agent for therapy of patients with acute lymphoblastic leukemia: are we there and are there pitfalls?
    Cronstein BN; Kamen BA
    J Pediatr Hematol Oncol; 2007 Dec; 29(12):805-7. PubMed ID: 18090925
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time.
    Smith PK; Carrier M; Chen JC; Haverich A; Levy JH; Menasché P; Shernan SK; Van de Werf F; Adams PX; Todaro TG; Verrier E
    Ann Thorac Surg; 2006 Sep; 82(3):781-8; discussion 788-9. PubMed ID: 16928483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary artery disease, ischemic preconditioning, and tolerance to ischemia.
    Ricci M; Salerno TA
    Crit Care Med; 2007 Oct; 35(10):2449-50. PubMed ID: 17885386
    [No Abstract]   [Full Text] [Related]  

  • 33. Preconditioning versus postconditioning: mechanisms and therapeutic potentials.
    Crisostomo PR; Wairiuko GM; Wang M; Tsai BM; Morrell ED; Meldrum DR
    J Am Coll Surg; 2006 May; 202(5):797-812. PubMed ID: 16648020
    [No Abstract]   [Full Text] [Related]  

  • 34. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
    Zhang JH; Chen ZW; Wu Z
    Can J Physiol Pharmacol; 2008 Mar; 86(3):131-8. PubMed ID: 18418440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
    Sivarajah A; McDonald MC; Thiemermann C
    Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrillatory arrest technique: is it worth tasting the old wine in new bottle?
    Mishra PK
    Eur J Cardiothorac Surg; 2006 May; 29(5):860; author reply 861. PubMed ID: 16520049
    [No Abstract]   [Full Text] [Related]  

  • 37. Limb ischemic postconditioning protects myocardium from ischemia-reperfusion injury.
    Li CM; Zhang XH; Ma XJ; Luo M
    Scand Cardiovasc J; 2006 Oct; 40(5):312-7. PubMed ID: 17012143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ischemic pre- and postconditioning].
    Heusch G; Schulz R
    Dtsch Med Wochenschr; 2006 Sep; 131(39):2169-75. PubMed ID: 16991036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neglect of the coronary circulation: some critical remarks on problems in the translation of cardioprotection.
    Heusch G; Schulz R
    Cardiovasc Res; 2009 Oct; 84(1):11-4. PubMed ID: 19546174
    [No Abstract]   [Full Text] [Related]  

  • 40. Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion.
    Prasad A; Stone GW; Holmes DR; Gersh B
    Circulation; 2009 Nov; 120(21):2105-12. PubMed ID: 19933949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.